Literature DB >> 25746964

Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome may have a hypothalamus-periaqueductal gray localization.

Cristelle Chow1, Marielle Valerie Fortier2, Lena Das3, Anuradha P Menon4, Rashida Vasanwala5, Joyce C M Lam6, Zhi Min Ng7, Simon Robert Ling1, Derrick W S Chan1, Chew Thye Choong1, Wendy K M Liew1, Terrence Thomas8.   

Abstract

BACKGROUND: Anatomical localization of the rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome has proved elusive. Most patients had neuroimaging after cardiorespiratory collapse, revealing a range of ischemic lesions. PATIENT DESCRIPTION: A 15-year-old obese boy with an acute febrile encephalopathy had hypoventilation, autonomic dysfunction, visual hallucinations, hyperekplexia, and disordered body temperature, and saltwater regulation. These features describe the ROHHAD syndrome. Cerebrospinal fluid analysis showed pleocytosis, elevated neopterins, and oligoclonal bands, and serology for systemic and antineuronal antibodies was negative. He improved after receiving intravenous steroids, immunoglobulins, and long-term mycophenolate. Screening for neural crest tumors was negative.
CONCLUSION: Magnetic resonance imaging of the brain early in his illness showed focal inflammation in the periaqueductal gray matter and hypothalamus. This unique localization explains almost all symptoms of this rare autoimmune encephalitis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ROHHAD syndrome; autoimmune encephalitis; hypothalamus; periaqueductal gray matter

Mesh:

Year:  2015        PMID: 25746964     DOI: 10.1016/j.pediatrneurol.2014.11.019

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

Review 1.  Guidelines for Treatment and Monitoring of Adult Survivors of Pediatric Brain Tumors.

Authors:  Anna J Janss; Claire Mazewski; Briana Patterson
Journal:  Curr Treat Options Oncol       Date:  2019-02-09

2.  Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine Tumors (ROHHADNET) Syndrome: A Systematic Review.

Authors:  Jiwon M Lee; Jaewon Shin; Sol Kim; Heon Yung Gee; Joon Suk Lee; Do Hyeon Cha; John Hoon Rim; Se-Jin Park; Ji Hong Kim; Ahmet Uçar; Andreas Kronbichler; Keum Hwa Lee; Jae Il Shin
Journal:  Biomed Res Int       Date:  2018-11-21       Impact factor: 3.411

3.  Natural history of ROHHAD syndrome: development of severe insulin resistance and fatty liver disease over time.

Authors:  Abdel Wahab Jalal Eldin; Dilara Tombayoglu; Laura Butz; Alison Affinati; Rasimcan Meral; Mehmet Selman Ontan; Kelly Walkovich; Maria Westerhoff; Jeffrey W Innis; Neehar D Parikh; Elif A Oral
Journal:  Clin Diabetes Endocrinol       Date:  2019-07-09

4.  Case Report: COVID-19-Associated ROHHAD-Like Syndrome.

Authors:  Irina N Artamonova; Natalia A Petrova; Natalia A Lyubimova; Natalia Yu Kolbina; Alexander V Bryzzhin; Alexander V Borodin; Tatyana A Levko; Ekaterina A Mamaeva; Tatiana M Pervunina; Elena S Vasichkina; Irina L Nikitina; Anna M Zlotina; Alexander Yu Efimtsev; Mikhail M Kostik
Journal:  Front Pediatr       Date:  2022-03-31       Impact factor: 3.418

5.  ROHHAD syndrome without rapid-onset obesity: A diagnosis challenge.

Authors:  Blandine Desse; Antoine Tran; Mathilde Butori; Sarah Marchal; Michael Afanetti; Sébastien Barthélemy; Etienne Bérard; Elisabeth Baechler; Stéphane Debelleix; Marie-Emilie Lampin; Julie Macey; Bruno Massenavette; Julie Harvengt; Ha Trang; Lisa Giovannini-Chami
Journal:  Front Pediatr       Date:  2022-08-31       Impact factor: 3.569

6.  Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumours.

Authors:  Sarah F Barclay; Casey M Rand; Lauren A Borch; Lisa Nguyen; Paul A Gray; William T Gibson; Richard J A Wilson; Paul M K Gordon; Zaw Aung; Elizabeth M Berry-Kravis; Diego Ize-Ludlow; Debra E Weese-Mayer; N Torben Bech-Hansen
Journal:  Orphanet J Rare Dis       Date:  2015-08-25       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.